Evaluation of the Effect of Acetazolamide, Mannitol and N-acetylcysteine on Cisplatin-Induced Nephrotoxicity

PHASE2CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2016

Conditions
Cisplatin Nephrotoxicity
Interventions
DRUG

Acetazolamide

patients received acetazolamide 250 mg half an hour before cisplatin with saline hydration.for prevention of cisplatin nephrotoxicity

DRUG

Acetylcysteine

patients received NAC (600 mg every 12 hours) for 4 doses beginning 24 hours before cisplatin with saline hydration.for prevention of cisplatin nephrotoxicity

DRUG

Mannitol

patients received mannitol 20 % 100 ml half an hour before cisplatin and saline hydration.

DRUG

saline

saline hydration 2500 ml before cisplatin therapy

DRUG

Cisplatin

patients with tumours already prescribed cisplatin

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT02760901 - Evaluation of the Effect of Acetazolamide, Mannitol and N-acetylcysteine on Cisplatin-Induced Nephrotoxicity | Biotech Hunter | Biotech Hunter